Natural products for antithrombosis
C Chen, FQ Yang, Q Zhang, FQ Wang… - Evidence‐Based …, 2015 - Wiley Online Library
Thrombosis is considered to be closely related to several diseases such as atherosclerosis,
ischemic heart disease and stroke, as well as rheumatoid arthritis, hyperuricemia, and …
ischemic heart disease and stroke, as well as rheumatoid arthritis, hyperuricemia, and …
[HTML][HTML] Direct-acting oral anticoagulants as prophylaxis against thromboembolism in the nephrotic syndrome
We report 2 cases of apixaban use as prophylaxis against thromboembolism in the
nephrotic syndrome (NS), and review the existing literature on direct-acting oral …
nephrotic syndrome (NS), and review the existing literature on direct-acting oral …
Efficacy and safety of the target-specific oral anticoagulants for stroke prevention in atrial fibrillation: the real-life evidence
V Russo, A Rago, R Proietti, F Di Meo… - … Advances in Drug …, 2017 - journals.sagepub.com
The aim of our article is to provide a concise review for clinicians entailing the main studies
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …
[PDF][PDF] Acupuncture safety in patients receiving anticoagulants: a systematic review
M McCulloch, A Nachat, J Schwartz… - Perm …, 2015 - thepermanentejournal.org
Introduction: Theoretically, acupuncture in anticoagulated patients could increase bleeding
risk. However, precise estimates of bleeding complication rates from acupuncture in …
risk. However, precise estimates of bleeding complication rates from acupuncture in …
Spinal subarachnoid hemorrhage in cortical superficial siderosis after apixaban and clopidogrel therapy
JG Heckmann - Journal of thrombosis and thrombolysis, 2016 - Springer
A 78-year-old man developed back pain without fever and headache. On admission, he
showed pronounced positive Lasegue test without focal abnormalities. Due to atrial …
showed pronounced positive Lasegue test without focal abnormalities. Due to atrial …
Emergency reversal of anticoagulation: novel agents
M Levine, JN Goldstein - Current neurology and neuroscience reports, 2014 - Springer
Historically, oral anticoagulation involved the administration of vitamin K antagonists, such
as warfarin. However, because of the need for frequent monitoring and the desire for safer …
as warfarin. However, because of the need for frequent monitoring and the desire for safer …
The development of new low-molecular-weight factor Xa inhibitors that are potential anticoagulants
DG Tovbin, DN Tarasov, DV Malakhov… - Current Drug …, 2022 - ingentaconnect.com
Background: Despite the introduction of direct oral anticoagulants, the search for new oral
anticoagulants remains an urgent task. Objective: By using docking and scoring, based on …
anticoagulants remains an urgent task. Objective: By using docking and scoring, based on …
Effects of rivaroxaban on platelet aggregation
J Hernandez-Juarez, HG Espejo-Godinez… - Journal of …, 2020 - journals.lww.com
Rivaroxaban is a direct oral anti-factor Xa anticoagulant. It has recently been suggested that
rivaroxaban may affect platelet function in vitro; however, little is known about the clinical …
rivaroxaban may affect platelet function in vitro; however, little is known about the clinical …
Novel oral anticoagulants in the management of coronary artery disease
SR McMahon, K Brummel-Ziedins… - Coronary Artery …, 2016 - journals.lww.com
Despite advances in interventional and pharmacologic therapy, survivors of myocardial
infarction remain at an increased risk of subsequent cardiovascular events. Initial …
infarction remain at an increased risk of subsequent cardiovascular events. Initial …
Computational studies of drug-binding kinetics
GK Ganotra - 2020 - archiv.ub.uni-heidelberg.de
The drug-receptor binding kinetics are defined by the rate at which a given drug associates
with and dissociates from its binding site on its macromolecular receptor. The lead …
with and dissociates from its binding site on its macromolecular receptor. The lead …